AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
Tag: pipeline
Recursion cuts nearly half of its pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
At investor event, Roche projects confidence on obesity pipeline
LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ ...
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
Sage suffers pipeline setback with failure of drug to treat essential tremor
Sage Therapeutics said Wednesday that an experimental pill failed to quell involuntary muscle shaking in patients with a neurological condition ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!